SUJAY KANGO - 30 Mar 2022 Form 4 Insider Report for INFINITY PHARMACEUTICALS, INC.

Role
Director
Signature
/s/ Seth A. Tasker, attorney-in-fact
Issuer symbol
N/A
Transactions as of
30 Mar 2022
Net transactions value
$0
Form type
4
Filing time
31 Mar 2022, 19:08:25 UTC
Previous filing
23 Nov 2021
Next filing
07 Jul 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INFI Stock Option (right to buy) Award $0 +90,000 $0.000000 90,000 30 Mar 2022 Common Stock 90,000 $1.13 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests as to 1/8th of the total number of shares on March 31, 2022 and as to 1/8th of the total number of shares at the end of each calendar quarter thereafter, provided that the Reporting Person continues to serve as a Director of the Issuer.